| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/03/2023 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 3.1k | $8.25 | $25.5k | | 10/03/2023 |
| 01/24/2023 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.6k | $21.90 | $34k | | 01/24/2023 |
| 10/04/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 3k | $25.68 | $78.1k | | 10/04/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 9.8k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.1k | $27.40 | $30.8k | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 39.4k | $27.50 | $1.1M | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 9.8k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 8k | $0.00 | $0 | | 01/31/2022 |
| 01/24/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.9k | $24.98 | $46.8k | | 01/24/2022 |
| 10/04/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 3.1k | $24.77 | $75.7k | | 10/04/2021 |
| 02/08/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.1k | $31.58 | $35.5k | | 02/05/2021 |
| 02/05/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.1k | $31.41 | $35.3k | | 02/05/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 563 | $28.91 | $16.3k | | 02/02/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 4.5k | $0.00 | $0 | | 02/03/2021 |
| 02/02/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 563 | $30.75 | $17.3k | | 02/02/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 15k | $0.00 | $0 | | 01/21/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 57.5k | $26.88 | $1.5M | | 01/21/2021 |
| 10/05/2020 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.2k | $19.35 | $42.3k | | 10/02/2020 |
| 10/02/2020 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.2k | $18.90 | $41.4k | | 10/02/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 9k | $0.00 | $0 | | 01/31/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 55k | $15.46 | $850.3k | | 01/31/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 9k | $0.00 | $0 | | 01/31/2020 |
| 10/01/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 100k | $11.25 | $1.1M | | 10/01/2019 |
| 10/01/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 35k | $0.00 | $0 | | 10/01/2019 |